These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20981523)

  • 1. Docking methods for structure-based library design.
    Cavasotto CN; Phatak SS
    Methods Mol Biol; 2011; 685():155-74. PubMed ID: 20981523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based and property-compliant library design of 11β-HSD1 adamantyl amide inhibitors.
    Paderes GD; Dress K; Huang B; Elleraas J; Rejto PA; Pauly T
    Methods Mol Biol; 2011; 685():191-215. PubMed ID: 20981525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular library design using multi-objective optimization methods.
    Nicolaou CA; Kannas CC
    Methods Mol Biol; 2011; 685():53-69. PubMed ID: 20981518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive combinatorial design of focused compound libraries.
    Schneider G; Schüller A
    Methods Mol Biol; 2009; 572():135-47. PubMed ID: 20694689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically.
    Hu Q; Peng Z; Kostrowicki J; Kuki A
    Methods Mol Biol; 2011; 685():253-76. PubMed ID: 20981528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors.
    Kolb P; Kipouros CB; Huang D; Caflisch A
    Proteins; 2008 Oct; 73(1):11-8. PubMed ID: 18384152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of lead compounds as antagonists of protein Bcl-xL with a diversity-oriented multidisciplinary approach.
    Di Micco S; Vitale R; Pellecchia M; Rega MF; Riva R; Basso A; Bifulco G
    J Med Chem; 2009 Dec; 52(23):7856-67. PubMed ID: 19852471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent thermolysin inhibitors using structure based virtual screening and binding assays.
    Khan MT; Fuskevåg OM; Sylte I
    J Med Chem; 2009 Jan; 52(1):48-61. PubMed ID: 19072688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A scalable approach to combinatorial library design.
    Sharma P; Salapaka S; Beck C
    Methods Mol Biol; 2011; 685():71-89. PubMed ID: 20981519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Free-Wilson selectivity analysis for combinatorial library design.
    Sciabola S; Stanton RV; Johnson TL; Xi H
    Methods Mol Biol; 2011; 685():91-109. PubMed ID: 20981520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial library design from reagent pharmacophore fingerprints.
    Chen H; Engkvist O; Blomberg N
    Methods Mol Biol; 2011; 685():135-52. PubMed ID: 20981522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BEAR, a novel virtual screening methodology for drug discovery.
    Degliesposti G; Portioli C; Parenti MD; Rastelli G
    J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
    Ebalunode JO; Zheng W; Tropsha A
    Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual medicinal chemistry: in silico pre-docking functional group transformation for discovery of novel inhibitors of botulinum toxin serotype A light chain.
    O'Malley S; Sareth S; Jiao GS; Kim S; Thai A; Cregar-Hernandez L; McKasson L; Margosiak SA; Johnson AT
    Bioorg Med Chem Lett; 2013 May; 23(9):2505-11. PubMed ID: 23545109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational approach to de novo discovery of fragment binding for novel protein states.
    Konteatis ZD; Klon AE; Zou J; Meshkat S
    Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based development of target-specific compound libraries.
    Orry AJ; Abagyan RA; Cavasotto CN
    Drug Discov Today; 2006 Mar; 11(5-6):261-6. PubMed ID: 16580603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.